Preser Cool Gel and Preser Kanpo Oral
Strengthening the Preser Hemorrhoid Treatment Line
 |
 |
| (Preser Cool Gel) |
(Preser Kanpo Oral) |
Taisho Pharmaceutical Co., Ltd., (President: Akira Uehara)
announced two additions to its Preser line of hemorrhoid treatments,
Preser Cool Gel, a transparent topical gel, and Preser Kanpo
Oral, which heals hemorrhoids while improving bowel movements,
on February 12, 2002.
Preser Cool Gel is Japan's first transparent gel type hemorrhoid
treatment. Smooth and non-sticky, it feels just cool enough
when applied to affected areas and delivers a high level of
both immediate and lasting therapeutic effects. This new treatment
received high marks in clinical trials and patent applications
have been submitted for the technology used to produce this
gel type hemorrhoid treatment.
Preser Kanpo Oral is made of traditional Chinese herbs that
heal hemorrhoids while easing the constipation that is one of
the leading causes of hemorrhoids. Through the action of the
traditional Otsuji-to herbal remedies from China, this treatment
provides effective internal and external relief and aids in
the healing of both hemorrhoids and anal fissures.
According to consumers surveyed by Taisho Pharmaceutical, individuals
prone to hemorrhoids are alerted to having hemorrhoids by the
discomfort of anal itching and swelling. Longtime sufferers
from hemorrhoids "hate sticky feeling treatments" and "want
quicker relief." Consumers also recognize that constipation
is one of the causes of hemorrhoids and that unless constipation
is relieved hemorrhoids are difficult to cure. The two new products
described above have been created in response to these consumer
needs.
The first treatment in the Preser series was launched in August,
1957. "Stop it and keep it stopped" Preser Ace is now the series'
leading product, has won praise as both an effective remedy
and an example of pharmaceutical manufacturing technology, and
has long been established as one of the highest ranking products
in its category. The new Preser Cool Gel and Preser Kanpo Oral
bring new strength to the Preser series.
|
Preser Cool Gel
| Product Features |
| 1. |
Smooth, non-sticky clear gel |
| 2. |
Outstanding therapeutic effects |
| 3. |
Instantly feels cool when applied |
Product Overview
| Product name |
Preser Cool Gel |
| Retail price |
800 yen (1 tube contains 15 g) |
| Active ingredients |
| (per 100 g) |
| Chlorpheniramine |
0.2g |
| l-menthol |
0.1g |
| Lidocaine |
3g |
| Tetrahydrozoline |
0.05g |
| Benzalkonium chloride |
0.05g |
| Additives: polyoxyethylene
castor oil |
|
| Indications |
For relief of itching, swelling, pain and
bleeding associated with hemorrhoids and anal fissures and disinfection
of the affected area. |
| Dosage |
Apply a suitable amount on affected areas
around the anus, 1-3 times/day. |
| Date of release |
February 12, 2002 |
| Expected sales |
300 million yen in first year |
Preser Kanpo Oral
| Product Features |
| 1. |
When taken internally, Otsuji-to improves bowel movements, lowering
the risk of hemorrhoids. |
| 2. |
Relieves all forms of hemorrhoids and anal fissures, both internal
and external. |
| 3. |
While preventing constipation that causes hemorrhoids, it also
provides symptomatic relief. |
Product Overview
| Product name |
Preser Kanpo Oral |
| Retail price |
2,700 yen for 30 packets |
| Active ingredients |
| (per daily dosage = three 2g packets) |
| Otsuji-to extract |
3.4g |
| (below are the equivalent amounts of extract) |
| Rhubarb |
0.5g |
| Cimicifuga Rhizome |
0.75g |
| Scutellaria Root |
1.5g |
| Bupleurum Root |
2.5g |
| Glycyrrhiza |
1.0g |
| Japanese Angelica Root |
3.0g |
|
| Indications |
For relief of the following symptoms arising from
hardened stools and tendency to constipation: hemorrhoids, anal
fissures, constipation. |
| Dosage |
The following amounts should be taken before eating
or with meals, i.e., within 2-3 hours of eating.
| Age |
15-plus |
7-14 |
4-6 |
2-3 |
Under 2 |
| Dose |
1 packet |
2/3 packet |
1/2 packet |
1/3 packet |
1/4 packet |
| Frequency |
3 times a day |
| [Notes] |
1. |
Use only as directed in the prescribed amount. |
|
2. |
Administer to children only under the supervision
of a parent or guardian. |
|
3. |
Do not give to children under the age of one
unless absolutely necessary. |
|
| Date of release |
February 12, 2002 |
| Expected sales |
200 million yen |
|
